课题基金 / 基金详情

Implantable Cardioverter Defibrillator Selection to Improve Survival in Left Ventricular Systolic Dysfunction: ISIS-LVSD Study (Ontario ICD Database Phase 2)

Implantable Cardioverter Defibrillator Selection to Improve Survival in Left Ventricular Systolic Dysfunction: ISIS-LVSD Study (Ontario ICD Database Phase 2)
选择植入式心脏复律除颤器以提高左心室收缩功能障碍患者的生存率：ISIS-LVSD 研究（安大略省 ICD 数据库第 2 期）
批准号：
212147
负责人：
Lee Douglas S
金额：
$42.91万
依托单位：
Institute for Clinical Evaluative Sciences-Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-09-01 至 2014-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=212147&lang=en
关键词：
Complications Implantable Cardioverter Defibrillators Left Ventricular Dysfunction Outcomes Sudden Cardiac Death Ventricular Arrhythmias

项目摘要

项目成果

Lee Douglas S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Implantable cardioverter defibrillators are small devices that are implanted under the skin to detect and treat serious, life-threatening heart rhythm disorders that can lead to sudden cardiac death. Although implantable defibrillators are now commonly us
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Population-estimable frailty using ‘big data’ to predict Covid-19 infection and illness severity, Institute of Clinical Evaluative Sciences
Improving Canadian Outcomes Research On the Novel SARS-CoV-2 using Analytics: the CORONA Consortium
  • 批准号：
    429867
  • 项目类别：
    Operating Grants
  • 资助金额：
    $29.81万
  • 财政年份：
    2020
  • 负责人：
    Lee Douglas S
  • 依托单位：
    University Health Network (Toronto)
BaSIS Risk Score for Primary Prevention Implantable Cardioverter Defibrillators
Program of Research on Outcomes, Treatment, and Evaluation of Care in the Spectrum of HF (PROTECT HF)
海外基金